Laboratory Information:
National Cancer Institute
Bethesda, MD 20892
Website: http://www.cancer.gov
Technology Transfer Website: http://ttc.nci.nih.gov/
Agency/Department: Dept. of Health and Human Services
Region: Mid-Atlantic
FLC Laboratory Representative:
Ms. Karen Maurey
Phone: (240) 276-5530
Fax: (240) 276-5504
Email: maureyk@mail.nih.gov
Background/History of the Laboratory:
The National Cancer Institute (NCI) is a component of
the National Institutes of Health (NIH), one of eight
agencies that compose the Public Health Service (PHS) in the Department of Health and Human Services
(DHHS). The NCI, established under the National Cancer Act of 1937, is the Federal Government's principal
agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and
responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments
have maintained the NCI authorities and responsibilities and added new information dissemination mandates
as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical
practice.
The National Cancer Institute coordinates the National Cancer Program, which conducts and supports
research, training, health information dissemination, and other programs with respect to the cause,
diagnosis,
prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients
and
the families of cancer patients.
Accomplishments in Technology Transfer:
AIDS test kits, Fludara®, Gardasil®, HIVID®,
Kepivance®, Multi-replica blotting kit for proteins, NeuTrexin®,
PathVysion® HER-2 DNA probe kit, PhenoSenseTM HIV phenotype tests, PixCell® Laser Capture
Microdissection system (LCM), Prezista®, soluble IL-2 receptor assays, Squirrel-Free capsaicin-treated
birdseed, Taxol®, Velcade®, Videx®, Vitravene® and Zevalin®. More information
on NCI success stories can be
found at
http://ttc.nci.nih.gov/mission/success.php
Mission of the Laboratory:
The National Cancer Institute supports
and coordinate research projects conducted by universities, hospitals,
research foundations, and businesses throughout this country and abroad through research grants and
cooperative agreements; conducts research in its own laboratories and clinics; supports education and
training in
fundamental sciences and clinical disciplines for participation in basic and clinical research programs
and
treatment programs relating to cancer through career awards, training grants, and fellowships; supports
research
projects in cancer control; supports a national network of cancer centers; collaborates with voluntary
organizations
and other national and foreign institutions engaged in cancer research and training activities; encourages
and
coordinates cancer research by industrial concerns where such concerns evidence a particular capability
for
programmatic research; collects and disseminates information on cancer; supports construction of laboratories,
clinics, and related facilities necessary for cancer research through the award of construction grants.
Technology Transfer Mechanisms:
- Clinical Trial Agreements (CTAs)
- Confidential Disclosure Agreements (CDAs)
- Employee Invention Report (EIR)
- Fellowships
- Material Transfers
- Materials-Cooperative Research and Development Agreement (Materials CRADA)
- Natural Products Branch-Developmental Therapeutics Program Memorandum of Understanding (MOU)
- Cooperative Research and Development Agreements (CRADAs)
- Small Business Innovative Research (SBIR)
Technology Areas of Expertise:
- AIDS Cancers
- Analytic Epidemiology
- Applied Cancer Screening
- Basic and Biobehavioral Research
- Basic Prevention Science
- Behavioral Research
- Biochemistry and Pharmacology
- Biological Modifiers
- Biometry
- Cancer and Nutrition
- Cancer Biology
- Cancer Biomarkers
- Cancer Cell Biology
- Cancer Complementary and Alternative Medicine
- Cancer Control and Population Sciences
- Cancer Etiology
- Cancer Genomics
- Cancer Immunology and Hematology
- Cancer Nanotechnology
- Cancer Prevention
- Cancer Statistics
- Cancer Surveillance
- Cancer Survivorship
- Cancer Treatment and Diagnosis
- Chemopreventive Agent Development
- Clinical and Genetic Epidemiology
- Clinical Oncology
- Clinical Proteomics Technology
- Clinical Trials
- Community Oncology Prevention Trials
- Diagnostic Imaging
- Diagnostics Research
- DNA and Chromosome Aberrations
- Drug Discovery
- Early Detection
- Epidemiology and Genetics
- Gastrointestinal and Other Cancers
- Health Communication and Informatics
- Health Promotion
- Health Services and Economics
- Imaging Technology Development
- Integrated Tumor Biology
- Integrated Tumor Biology
- Lung and Upper Aerodigestive Cancer
- Molecular Imaging
- Mouse Models of Human Cancers
- Nutritional Science
- Outcomes Research
- Prostate and Urologic Cancer
- Radiotherapy Development
- Resources Development
- Risk Factor Monitoring and Methods
- Statistical Research and Applictions
- Surgical Oncology
- Surveillance Research
- Technology Development/Cancer Diagnosis Program
- Tobacco Control and Research
- Tumor Biology and Metastasis
